A two-part phase 1 study to establish and compare the safety and local tolerability of two nasal formulations of XF-73 for decolonisation of Staphylococcus aureus: A previously investigated 0.5 mg/g viscosified gel formulation versus a modified formulation-Reference-Cited by-同舟云学术

A two-part phase 1 study to establish and compare the safety and local tolerability of two nasal formulations of XF-73 for decolonisation of Staphylococcus aureus: A previously investigated 0.5 mg/g viscosified gel formulation versus a modified formulation

Published:2020-06 Issue: Volume:21 Page:171-180
ISSN:2213-7165
Container-title:Journal of Global Antimicrobial Resistance
language:en
Short-container-title:Journal of Global Antimicrobial Resistance

Author:

Yendewa George A.,Griffiss J. McLeod,Jacobs Michael R.,Fulton Scott A.,O’Riordan Mary Ann,Gray Wesley A.,Proskin Howard M.,Winkle Peter,Salata Robert A.

Publisher

Elsevier BV

Subject

Microbiology (medical),Immunology,Immunology and Allergy,Microbiology

Reference21 articles.

1. An overview of nosocomial infections, including the role of the microbiology laboratory;Emori;Clin Microbiol Rev,1993

2. Nasal carriage as a source of Staphylococcus aureus bacteremia;Von Eiff;N Engl J Med,2001

3. The relation between nasal-staphylococcal-carrier state and the incidence of postoperative complications;Weinstein;N Engl J Med,1959

4. Healthy carriage of Staphylococcus aureus: its prevalence and importance;Williams;Bacteriol Rev,1963

5. New approaches to reduce Staphylococcus aureus nosocomial infection rates: treating S. aureus nasal carriage;Perl;Ann Pharmacother,1998

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment of MRSA Infection: Where are We?;Current Medicinal Chemistry;2024-08

2. Bacterial persisters: molecular mechanisms and therapeutic development;Signal Transduction and Targeted Therapy;2024-07-17

3. Eradication of community-onset Methicillin-resistant Staphylococcus aureus carriage: a narrative review;Clinical Microbiology and Infection;2024-01

4. Screening of the novel antimicrobial drug, XF-73, against 2,527 Staphylococcus species clinical isolates;Frontiers in Cellular and Infection Microbiology;2023-10-11

5. Staph wars: the antibiotic pipeline strikes back;Microbiology;2023-09-01